Results
94
FGF and Nodal signals function synergistically during heart tube formation 95
Previous studies have revealed that the left-sided activation of Nodal within the anterior LPM 96
produces directional migration of CPCs and thus determines the direction of heart tube displacement 97
from the embryonic midline during cardiac jogging (Baker et al., 2008; de Campos-Baptista et al., 2008; 98
Kidokoro et al., 2022; Lenhart et al., 2013; Rohr et al., 2008; Veerkamp et al., 2013). To elucidate 99
mechanisms by which Nodal induces left-right asymmetries in CPC migration rates, we mined our 100
previous microarray studies identifying cardiac-specific transcriptional targets of Nodal. We found a 101
number of components of the FGF signaling pathway as being upregulated by Nodal signals, including 102
FGF ligands, transcriptional targets, and three of four tyrosine kinase receptors (FGFRs; Williams, 103
2015). Interestingly, various genes involved in FGF signaling have been previously identified as Nodal 104
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
targets in zebrafish, including fgf17b, fgf3, and fgf8 (Bennett et al., 2007), and fgf8 is expressed in the 105
cardiac cone prior to cardiac jogging (Fig. 1A; Reifers et al., 1998; Reifers et al., 2000). 106
To explore the function of FGF signals during heart development, we administered the pan-107
FGFR inhibitor SU5402 (Mohammadi et al., 1997). Because inhibition of FGF signaling can affect 108
cardiac precursor development (Felker et al., 2018; Marques et al., 2008; Reifers et al., 2000), the use 109
of SU5402 enables precise temporal control over the inhibition of FGF signaling after CPC 110
specification. The addition of SU5402 at 24 hpf resulted in various cardiac defects, including severe 111
pericardial edema and aberrant chamber placement, implicating a role for FGF in asymmetric cardiac 112
morphogenesis (Fig. 1B). 113
To confirm that treatment with SU5402 did not affect the expression of left-right patterning 114
genes, we analyzed the effect of inhibiting FGF signaling at 18.5 hpf on expression of the Nodal target 115
gene lefty2 in the cardiac cone. lefty2 expression serves as both a readout of Nodal responsiveness 116
and a direct readout of the sidedness of Nodal in the embryo (Fig. 1C). In WT embryos, lefty2 117
expression was restricted to the left in the cardiac cone, as expected (Fig. 1D). spaw mutants lacked 118
lefty2 expression (Grimes et al., 2020; Noel et al., 2013), while the majority of ntl mutants expressed 119
lefty2 bilaterally (Amack and Yost, 2004), as expected (Fig. 1D). Loss of FGF signaling in SU5402-120
treated WT embryos did not alter the left-sidedness of Nodal target lefty2, nor did loss of FGF change 121
the expression profile of lefty2 in spaw and ntl mutants (Fig. 1D), suggesting that any effect of FGF on 122
asymmetric chamber placement was downstream of left-right axis establishment. 123
To explore the function of FGF signals during cardiac jogging, the first morphological break in 124
symmetry in the embryo, we administered SU5402 at 18.5 hpf, just before the formation of the cardiac 125
cone, and continued treatment until assessment at 24 hpf (Fig. 2A), a time at which most wild-type 126
(WT) embryos have completed extension of the cardiac cone into a linear heart tube (Fig. 2B). As 127
expected, most WT embryos had completed migration and jogging (Fig. 2C). no tail (ntl/ta) mutants, 128
which have bilateral Nodal expression in the LPM (Amack and Yost, 2004), exhibited only a slight delay 129
in cone-to-tube transition, with most embryos having completed jogging at this time point (Fig. 2C). By 130
contrast, southpaw (spaw) mutants, which lack Nodal expression in the LPM (Grimes et al., 2020; Noel 131
et al., 2013), displayed a significant delay in tube formation with the majority of hearts remaining at 132
cone stage or starting to extend (Fig. 2C). SU5402-treated WT embryos also experienced a significant 133
delay in tube formation, suggesting a role for FGF signaling in promoting CPC motility in this process 134
(Fig. 2C). Interestingly, treating ntl and spaw mutants with SU5402 significantly increased delays in 135
tube formation, with most hearts remaining in the cardiac cone stage (Fig. 2C). The strongest effect 136
was observed in spaw mutants treated with SU5402, in which all hearts of embryos analyzed remained 137
at the cardiac cone stage at 24 hpf (Fig. 2C). While heart tube formation was delayed at 24 hpf in 138
SU5402-treated and mutant embryos, heart tubes eventually formed in all groups after several 139
additional hours (Fig. 2D,F). Heart tubes were significantly shorter in SU5402-treated embryos, likely 140
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
due to inhibition of SHF addition as previously reported (Fig. 2D; de Pater et al., 2009; Felker et al., 141
2018; Lazic and Scott, 2011). Heart tubes were also shorter in ntl and spaw mutants, suggesting that 142
elongation is impacted in these mutants or that elongating in a midline position may be inhibited by 143
surrounding tissues (Fig. 2D). 144
To determine if inhibiting FGF signaling causes defects in cardiac laterality, we examined the 145
direction of heart jogging in embryos with extended heart tubes at 26.5 hpf (Fig. 2E). In WT embryos, 146
heart tubes were displaced to the left of the embryonic midline, producing the expected “left jog” (Fig. 147
2F). spaw mutants and ntl mutants exhibited primarily “midline jog”, in which the heart tube fails to be 148
displaced to either side of the midline, as expected (Fig. 2F). Though inhibiting FGF signaling affected 149
the dynamics of heart tube formation, hearts consistently jogged correctly to the left (Fig. 2F), 150
suggesting that FGF signaling is dispensable for instructing cardiac laterality at this point. Overall, this 151
suggests that Nodal and FGF signaling cooperate to promote cell migration during jogging, while only 152
Nodal signaling is required to induce lateralized migration during this process. 153
154
Nodal and FGF signals regulate the velocity dynamics and directionality of CPCs during heart 155
tube formation 156
Perturbation of the Nodal and FGF pathways resulted in defects in heart tube morphogenesis 157
that we hypothesized were due to defects in cell migration. To explore this possibility, we conducted 158
confocal live imaging of embryos that express EGFP under the cardiac-specific myl7 promoter (Huang 159
et al., 2003) to quantify metrics of cell migration (Fig. 3A). Starting from the formation of the cardiac 160
cone, cell movements were analyzed for three hours in each condition. WT embryos completed jogging 161
within the three-hour time frame and formed a left-lateralized heart tube (Fig. 3B; Movie S1). ntl 162
mutants completed jogging in the same time frame but produce midline jogged heart tubes due to 163
bilateral Nodal expression (Fig. 3B; Movie S2). spaw mutants also display midline jogging; however, 164
these CPCs migrated more slowly compared to WT or ntl mutants, often resulting in incomplete tube 165
extension during the three-hour time frame (Fig. 3B; Movie S3). Similarly, CPCs in SU5402-treated WT 166
embryos migrated more slowly compared to WT or ntl mutants, resulting in incomplete tube extension 167
during the imaging time frame (Fig. 3B; Movie S4). Intriguingly, CPCs in SU5402-treated spaw mutants 168
scarcely migrated during the same time frame and exhibited a severe delay in heart tube formation 169
(Fig. 3B; Movie S5). These results indicate that FGF signaling acts as a CPC migration stimulus during 170
jogging and acts cooperatively with Nodal in this process. 171
To better characterize asymmetric migration during jogging, we quantified the trajectories of 172
CPCs by tracking them throughout the duration of the time-lapse movies (Fig. 3C). As the outermost 173
atrial cells of the cardiac cone display the largest disparity in left-right migration rates, we analyzed the 174
movements of this population; the brighter, inner ventricular cells were not included in our analysis. 175
Analysis of the direction and magnitude of CPC trajectories revealed that CPCs in WT embryos 176
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
exhibited a marked anterior and leftward displacement, while CPCs in ntl and spaw mutants failed to 177
undergo strong left or right displacement (Fig. 3D). Furthermore, in ntl and spaw mutants, overall 178
anterior displacement of CPCs was decreased (Fig. 3D). SU5402-treated embryos displayed a leftward 179
bias, though the overall displacement was not as marked as in WT embryos, and anterior migration 180
was reduced in these embryos (Fig. 3D). Lateral and anterior migrations were most severely disrupted 181
in SU5402-treated spaw mutants, further confirming that Nodal and FGF signals work cooperatively to 182
promote CPC migration during jogging (Fig. 3D). The CPC trajectories further suggest that Nodal and 183
FGF signals contribute to the general anterior migration of the heart during jogging, while asymmetric 184
Nodal signals promote lateral migration. 185
To better understand how Nodal and FGF signals contribute to cardiac laterality, we analyzed 186
the migration velocities of CPCs. Cardiac laterality is known to be directed by left-right biases in cell 187
migration velocity driven by Nodal signaling, with left CPCs displaying a higher velocity that right CPCs 188
in WT embryos (de Campos-Baptista et al., 2008; Kidokoro et al., 2022; Lenhart et al., 2013; Veerkamp 189
et al., 2013). We found that only in WT embryos did strong asymmetric migration velocities exist, with 190
left-sided cardiac cone cells exhibiting significantly higher velocities than right-sided cells (Fig. 3E). 191
Given the bilateral exposure to Nodal of CPCs in ntl mutants, we expected migration to be increased on 192
both sides of the cardiac cone as we observed in ntl morphants (Lenhart K. F. et al., 2013). However, 193
we found that ntl mutants did not display increased migration velocities compared to WT; nevertheless, 194
the expected symmetry in migration velocities was observed (Fig. 3E). Consistent with previous 195
findings (de Campos-Baptista et al., 2008; Kidokoro et al., 2022; Lenhart et al., 2013; Veerkamp et al., 196
2013), migration velocities of CPCs in spaw mutants are symmetric and reduced compared to WT (Fig. 197
3E). Treatment with SU5402 in WT embryos produced a pronounced reduction of migration velocity 198
similar to that of ntl and spaw mutants (Fig. 3E). We did observe weak asymmetry in left versus right 199
migration velocities, as is expected given these heart tubes jog correctly to the left and Nodal 200
expression is unaffected in these embryos (Fig. 1D, 2F, 3E). However, the differences in left versus 201
right velocities were not statistically significant in this analysis. Intriguingly, SU5402-treated spaw 202
mutants had a more severe reduction in migration velocity compared to spaw mutants or SU5402-203
treated embryos, further suggesting cooperation between Nodal and FGF signals in this process (Fig. 204
3E). Taken together, our findings on CPC migration, velocity, and trajectories all support Nodal acting 205
to bias left migration velocities, while FGF acts with Nodal to promote overall CPC velocities during 206
heart tube morphogenesis. 207
208
Nodal elicits left-right asymmetries in migration by inducing left-right asymmetries in actin 209
polymerization in CPCs 210
Though previous studies have elucidated a role for the Nodal pathway in governing cardiac 211
laterality, the molecular mechanisms by which the pathway does so remain unclear. A promising 212
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
possibility is that Nodal promotes cell migration by asymmetrically influencing the actin cytoskeleton 213
and its regulators during cardiac jogging. It is known that actin can be regulated by Nodal signaling 214
during cardiac looping and in other developmental contexts (Noel et al., 2013; Woo et al., 2012). 215
Furthermore, FGF signaling is also known to regulate cytoskeletal dynamics, including actin 216
polarization (Sai and Ladher, 2008; Yang et al., 2020). To assess this possibility, we generated 217
Tg(myl7:Lifeact-EGFP) fish, in which EGFP-labeled filamentous actin (F-actin) is restricted to CPCs 218
(Huang et al., 2003; Reischauer et al., 2014; Riedl et al., 2008), permitting us to observe F-actin levels 219
and cellular protrusive activity (Fig. 4A). Two-photon imaging of the cardiac cone in WT Lifeact-EGFP 220
transgenics revealed left-sided atrial cells have higher levels of F-actin than the corresponding right-221
sided cells, and this asymmetry in F-actin persisted throughout jogging (Fig. 4B; Movie S6). Imaging 222
injected embryos mosaically expressing Lifeact-EGFP at the cellular level revealed numerous Lifeact-223
EGFP-positive protrusions in left-sided atrial cells where motility rates are high (Fig. 4C; Movie S7). 224
To determine if the higher F-actin levels we observe in left atrial cells are in response to Nodal 225
signaling, we examined actin dynamics in ntl morphants, in spaw morphants, and in embryos treated 226
with SB-505124, a pharmacological inhibitor of Nodal signaling that works well in zebrafish (DaCosta 227
Byfield et al., 2004; Hagos and Dougan, 2007). In WT embryos, left-sided CPCs exhibited high levels of 228
F-actin (Fig. 4D). No increase in F-actin levels in atrial cells was observed when Nodal signaling was 229
lost in spaw morphants or with administration of SB-505124 (Fig. 4D; Movies S8-9). Conversely, we 230
observed a symmetrical increase in F-actin level in ntl morphants, in which Nodal is expressed 231
bilaterally in the LPM (Fig. 4D; Movie S10). To quantify these results, we measured the ratio of 232
fluorescence intensity values between left-sided and right-sided cells (Fig. 4E). An intensity ratio of left-233
to-right cells greater than 1 is indicative of left-biased levels, while an intensity ratio equal to 1 indicates 234
symmetric levels. We found the fluorescence intensity ratio in WT embryos to be left-biased, which is 235
indicative of asymmetric F-actin levels (Fig. 4F). However, ntl morphants, spaw morphants, and 236
SB505124-treated embryos had ratios indicative of symmetric F-actin levels (Fig. 4F). Taken together, 237
these findings support our hypothesis that Nodal induces left-right asymmetries in migration velocity by 238
promoting actin cytoskeleton dynamics. 239
240
FGF signaling is necessary for cardiac looping 241
FGF signaling is known to influence various aspects of zebrafish heart morphogenesis, such as 242
CPC differentiation and proliferation, as well as chamber size and identity establishment (de Pater et 243
al., 2009; Felker et al., 2018; Lazic and Scott, 2011; Marques et al., 2008; Pradhan et al., 2017; Reifers 244
et al., 1998; Zeng and Yelon, 2014). In embryos treated with SU5402 from 24-48 hpf (continuous 245
treatment; Fig. 5A), differences in heart tube morphology between treated and vehicle-treated embryos 246
are apparent. SU5402-treated embryos exhibit defects in heart looping, chamber shape, and ventricle 247
size, as reported previously (Fig. 5B). Given the ostensible importance of FGF signaling in heart 248
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
looping, the second and more evolutionarily conserved asymmetry in heart development, we wanted to 249
determine if there was a more specific developmental window in which FGF signaling influences this 250
process. 251
To further investigate the role of FGF in cardiac looping, we treated embryos with SU5402 252
during more specific developmental windows: during the heart tube elongation phase (24-30 hpf, prior 253
to the onset of looping) and the heart tube bending phase (30-36 hpf, during looping; Fig. 5A). In 254
vehicle-treated embryos, the heart has completed looping and the atrium and ventricle are positioned 255
side-by-side at 48 hpf (Fig. 5B). Treatment during both of our defined developmental windows resulted 256
in a vertically “stacked” chamber phenotype indicative of looping defects (Fig. 5B). Quantification of 257
these chamber placement defects was conducted by measuring the looping angle: the angle formed by 258
the intersection of a line along the anterior-posterior axis and a line through the atrioventricular canal 259
(AVC) at 48 hpf, with a properly developed heart having a looping angle of ~25.0° (Chernyavskaya et 260
al., 2012). We found that SU5402 treatment during the elongation phase resulted in significantly larger 261
looping angles (mean looping angle = 41.2°), suggesting impaired looping, while treatment during the 262
bending phase was not significantly different than WT (Fig. 5C). This suggests FGF signaling between 263
24 to 30 hpf is important for proper heart looping. Heart looping is compromised in spaw mutants (Fig. 264
5C; mean looping angle = 65.1°), and we find loss of FGF signaling during the elongation phase in 265
spaw mutants exacerbates heart looping defects (Fig. 5C; mean looping angle 74.6°). Our results 266
suggest that Nodal and FGF cooperate to promote heart looping. 267
268
SHF addition is required for heart looping 269
Others have shown that loss of FGF signaling post 24 hpf prevents addition of the secondary 270
heart field (SHF) to the arterial pole of the heart tube. To determine if our treatment with SU5402 271
affected SHF addition during the elongation phase, we treated embryos starting at 24 hpf and imaged 272
the heart tube at both 26.5 and 28 hpf. Measuring heart tube length revealed significantly shorter heart 273
tubes in SU5402-treated embryos (Fig. 5D), indicative of loss of the SHF. This suggested to us that the 274
addition of SHF cells is critical for proper heart looping. To address this possibility, we injected embryos 275
at the 1-cell stage with a morpholino against ltbp3, a canonical SHF marker that is necessary for SHF 276
addition to the heart tube (Zhou et al., 2011), and assessed the heart at 48 hpf. ltbp3 morphants 277
exhibited looping and chamber placement defects similar to SU5402-treated embryos (Fig. 6A). 278
Quantification revealed the looping angle in morphants was significantly higher (mean looping angle = 279
51.1°) than in vehicle-injected embryos (mean looping angle = 25.8°; Fig. 6B). This indicates that 280
addition of SHF cells to the heart tube is needed for proper cardiac looping in vivo. 281
282
Loss of FGF signaling during elongation and bending phases compromises AVC development 283
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
SU5402 treatment during the elongation and bending phases produced aberrant chamber 284
morphologies with smaller ventricles and elongated atria (Fig. 5B). Intriguingly, it is known that 285
nppa/nppb double mutants exhibit abnormal atrial morphologies due to errors in AVC development; 286
AVC defects result in improper blood flow, which in turn cause defects in chamber ballooning (Auman 287
et al., 2007; Dietrich et al., 2014; Grassini et al., 2018). To determine if FGF inhibition influences AVC 288
development, we analyzed expression of nppa. nppa is typically expressed in the outer curvatures of 289
the heart chambers but is excluded from the AVC, a phenotype observed in vehicle-treated embryos 290
(Fig. 6C-D). In SU5402-treated embryos, nppa was expressed in the AVC, which is an abnormal nppa 291
expression pattern (Fig. 6C-D). Overall, these findings suggest that FGF signaling may influence 292
chamber morphology by promoting proper formation of the AVC. 293
294
References
494
Amack, J. D. and Yost, H. J. (2004). The T box transcription factor no tail in ciliated cells controls 495
zebrafish left-right asymmetry. Curr Biol 14, 685-690. 496
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
Auman, H. J., Coleman, H., Riley, H. E., Olale, F., Tsai, H. J. and Yelon, D. (2007). Functional 497
modulation of cardiac form through regionally confined cell shape changes. PLoS Biol 5, e53. 498
Baker, K., Holtzman, N. G. and Burdine, R. D. (2008). Direct and indirect roles for Nodal signaling in 499
two axis conversions during asymmetric morphogenesis of the zebrafish heart. Proc Natl Acad 500
Sci U S A 105, 13924-13929. 501
Bakkers, J. (2011). Zebrafish as a model to study cardiac development and human cardiac disease. 502
Cardiovasc Res 91, 279-288. 503
Bennett, J. T., Joubin, K., Cheng, S., Aanstad, P., Herwig, R., Clark, M., Lehrach, H. and Schier, 504
A. F. (2007). Nodal signaling activates differentiation genes during zebrafish gastrulation. Dev 505
Biol 304, 525-540. 506
Berdougo, E., Coleman, H., Lee, D. H., Stainier, D. Y. and Yelon, D. (2003). Mutation of weak 507
atrium/atrial myosin heavy chain disrupts atrial function and influences ventricular 508
morphogenesis in zebrafish. Development 130, 6121-6129. 509
Bisgrove, B. W., Essner, J. J. and Yost, H. J. (1999). Regulation of midline development by 510
antagonism of lefty and nodal signaling. Development 126, 3253-3262. 511
Chernyavskaya, Y., Ebert, A. M., Milligan, E. and Garrity, D. M. (2012). Voltage-gated calcium 512
channel CACNB2 (beta2.1) protein is required in the heart for control of cell proliferation and 513
heart tube integrity. Dev Dyn 241, 648-662. 514
Choi, H. M. T., Schwarzkopf, M., Fornace, M. E., Acharya, A., Artavanis, G., Stegmaier, J., Cunha, 515
A. and Pierce, N. A. (2018). Third-generation in situ hybridization chain reaction: multiplexed, 516
quantitative, sensitive, versatile, robust. Development 145. 517
DaCosta Byfield, S., Major, C., Laping, N. J. and Roberts, A. B. (2004). SB-505124 is a selective 518
inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. Mol 519
Pharmacol 65, 744-752. 520
de Campos-Baptista, M. I., Holtzman, N. G., Yelon, D. and Schier, A. F. (2008). Nodal signaling 521
promotes the speed and directional movement of cardiomyocytes in zebrafish. Dev Dyn 237, 522
3624-3633. 523
de Pater, E., Clijsters, L., Marques, S. R., Lin, Y. F., Garavito-Aguilar, Z. V., Yelon, D. and 524
Bakkers, J. (2009). Distinct phases of cardiomyocyte differentiation regulate growth of the 525
zebrafish heart. Development 136, 1633-1641. 526
Desgrange, A., Le Garrec, J. F. and Meilhac, S. M. (2018). Left-right asymmetry in heart 527
development and disease: forming the right loop. Development 145. 528
Dietrich, A. C., Lombardo, V. A., Veerkamp, J., Priller, F. and Abdelilah-Seyfried, S. (2014). Blood 529
flow and Bmp signaling control endocardial chamber morphogenesis. Dev Cell 30, 367-377. 530
Farooqui, R. and Fenteany, G. (2005). Multiple rows of cells behind an epithelial wound edge extend 531
cryptic lamellipodia to collectively drive cell-sheet movement. J Cell Sci 118, 51-63. 532
Felker, A., Prummel, K. D., Merks, A. M., Mickoleit, M., Brombacher, E. C., Huisken, J., Panakova, 533
D. and Mosimann, C. (2018). Continuous addition of progenitors forms the cardiac ventricle in 534
zebrafish. Nat Commun 9, 2001. 535
Genge, C. E., Lin, E., Lee, L., Sheng, X., Rayani, K., Gunawan, M., Stevens, C. M., Li, A. Y., Talab, 536
S. S., Claydon, T. W., et al. (2016). The Zebrafish Heart as a Model of Mammalian Cardiac 537
Function. Rev Physiol Biochem Pharmacol 171, 99-136. 538
Grant, M. G., Patterson, V. L., Grimes, D. T. and Burdine, R. D. (2017). Modeling Syndromic 539
Congenital Heart Defects in Zebrafish. Curr Top Dev Biol 124, 1-40. 540
Grassini, D. R., Lagendijk, A. K., De Angelis, J. E., Da Silva, J., Jeanes, A., Zettler, N., Bower, N. 541
I., Hogan, B. M. and Smith, K. A. (2018). Nppa and Nppb act redundantly during zebrafish 542
cardiac development to confine AVC marker expression and reduce cardiac jelly volume. 543
Development 145. 544
Grimes, D. T., Patterson, V. L., Luna-Arvizu, G., Schottenfeld-Roames, J., Irons, Z. H. and 545
Burdine, R. D. (2020). Left-right asymmetric heart jogging increases the robustness of dextral 546
heart looping in zebrafish. Dev Biol 459, 79-86. 547
Hagos, E. G. and Dougan, S. T. (2007). Time-dependent patterning of the mesoderm and endoderm 548
by Nodal signals in zebrafish. BMC Dev Biol 7, 22. 549
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
Halpern, M. E., Ho, R. K., Walker, C. and Kimmel, C. B. (1993). Induction of muscle pioneers and 550
floor plate is distinguished by the zebrafish no tail mutation. Cell 75, 99-111. 551
Hill, C. S. (2016). Transcriptional Control by the SMADs. Cold Spring Harb Perspect Biol 8. 552
Huang, C. J., Tu, C. T., Hsiao, C. D., Hsieh, F. J. and Tsai, H. J. (2003). Germ-line transmission of a 553
myocardium-specific GFP transgene reveals critical regulatory elements in the cardiac myosin 554
light chain 2 promoter of zebrafish. Dev Dyn 228, 30-40. 555
Kawakami, K. (2007). Tol2: a versatile gene transfer vector in vertebrates. Genome Biol 8 Suppl 1, 556
S7. 557
Kidokoro, H., Saijoh, Y. and Schoenwolf, G. C. (2022). Nodal signaling regulates asymmetric cellular 558
behaviors, driving clockwise rotation of the heart tube in zebrafish. Commun Biol 5, 996. 559
Lazic, S. and Scott, I. C. (2011). Mef2cb regulates late myocardial cell addition from a second heart 560
field-like population of progenitors in zebrafish. Dev Biol 354, 123-133. 561
Lenhart, K. F., Holtzman, N. G., Williams, J. R. and Burdine, R. D. (2013). Integration of nodal and 562
BMP signals in the heart requires FoxH1 to create left-right differences in cell migration rates 563
that direct cardiac asymmetry. PLoS Genet 9, e1003109. 564
Long, S., Ahmad, N. and Rebagliati, M. (2003). The zebrafish nodal-related gene southpaw is 565
required for visceral and diencephalic left-right asymmetry. Development 130, 2303-2316. 566
Marques, S. R., Lee, Y., Poss, K. D. and Yelon, D. (2008). Reiterative roles for FGF signaling in the 567
establishment of size and proportion of the zebrafish heart. Dev Biol 321, 397-406. 568
Massague, J. (2003). Integration of Smad and MAPK pathways: a link and a linker revisited. Genes 569
Dev 17, 2993-2997. 570
Mohammadi, M., McMahon, G., Sun, L., Tang, C., Hirth, P., Yeh, B. K., Hubbard, S. R. and 571
Schlessinger, J. (1997). Structures of the tyrosine kinase domain of fibroblast growth factor 572
receptor in complex with inhibitors. Science 276, 955-960. 573
Nasevicius, A. and Ekker, S. C. (2000). Effective targeted gene 'knockdown' in zebrafish. Nat Genet 574
26, 216-220. 575
Navarrete, I. A. and Levine, M. (2016). Nodal and FGF coordinate ascidian neural tube 576
morphogenesis. Development 143, 4665-4675. 577
Nguyen, C. T., Lu, Q., Wang, Y. and Chen, J. N. (2008). Zebrafish as a model for cardiovascular 578
development and disease. Drug Discov Today Dis Models 5, 135-140. 579
Noel, E. S., Verhoeven, M., Lagendijk, A. K., Tessadori, F., Smith, K., Choorapoikayil, S., den 580
Hertog, J. and Bakkers, J. (2013). A Nodal-independent and tissue-intrinsic mechanism 581
controls heart-looping chirality. Nat Commun 4, 2754. 582
Pradhan, A., Zeng, X. I., Sidhwani, P., Marques, S. R., George, V., Targoff, K. L., Chi, N. C. and 583
Yelon, D. (2017). FGF signaling enforces cardiac chamber identity in the developing ventricle. 584
Development 144, 1328-1338. 585
Regan, J. C., Concha, M. L., Roussigne, M., Russell, C. and Wilson, S. W. (2009). An Fgf8-586
dependent bistable cell migratory event establishes CNS asymmetry. Neuron 61, 27-34. 587
Reifers, F., Bohli, H., Walsh, E. C., Crossley, P. H., Stainier, D. Y. and Brand, M. (1998). Fgf8 is 588
mutated in zebrafish acerebellar (ace) mutants and is required for maintenance of midbrain-589
hindbrain boundary development and somitogenesis. Development 125, 2381-2395. 590
Reifers, F., Walsh, E. C., Leger, S., Stainier, D. Y. and Brand, M. (2000). Induction and differentiation 591
of the zebrafish heart requires fibroblast growth factor 8 (fgf8/acerebellar). Development 127, 592
225-235. 593
Reischauer, S., Arnaout, R., Ramadass, R. and Stainier, D. Y. (2014). Actin binding GFP allows 4D 594
in vivo imaging of myofilament dynamics in the zebrafish heart and the identification of Erbb2 595
signaling as a remodeling factor of myofibril architecture. Circ Res 115, 845-856. 596
Riedl, J., Crevenna, A. H., Kessenbrock, K., Yu, J. H., Neukirchen, D., Bista, M., Bradke, F., 597
Jenne, D., Holak, T. A., Werb, Z., et al. (2008). Lifeact: a versatile marker to visualize F-actin. 598
Nat Methods 5, 605-607. 599
Rohr, S., Bit-Avragim, N. and Abdelilah-Seyfried, S. (2006). Heart and soul/PRKCi and nagie 600
oko/Mpp5 regulate myocardial coherence and remodeling during cardiac morphogenesis. 601
Development 133, 107-115. 602
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
Rohr, S., Otten, C. and Abdelilah-Seyfried, S. (2008). Asymmetric involution of the myocardial field 603
drives heart tube formation in zebrafish. Circ Res 102, e12-19. 604
Roussigne, M., Wei, L., Tsingos, E., Kuchling, F., Alkobtawi, M., Tsalavouta, M., Wittbrodt, J., 605
Carl, M., Blader, P. and Wilson, S. W. (2018). Left/right asymmetric collective migration of 606
parapineal cells is mediated by focal FGF signaling activity in leading cells. Proc Natl Acad Sci 607
U S A 115, E9812-E9821. 608
Sai, X. and Ladher, R. K. (2008). FGF signaling regulates cytoskeletal remodeling during epithelial 609
morphogenesis. Curr Biol 18, 976-981. 610
Schier, A. F. (2009). Nodal morphogens. Cold Spring Harb Perspect Biol 1, a003459. 611
Shu, X., Cheng, K., Patel, N., Chen, F., Joseph, E., Tsai, H. J. and Chen, J. N. (2003). Na,K-ATPase 612
is essential for embryonic heart development in the zebrafish. Development 130, 6165-6173. 613
Smith, K. A., Chocron, S., von der Hardt, S., de Pater, E., Soufan, A., Bussmann, J., Schulte-614
Merker, S., Hammerschmidt, M. and Bakkers, J. (2008). Rotation and asymmetric 615
development of the zebrafish heart requires directed migration of cardiac progenitor cells. Dev 616
Cell 14, 287-297. 617
Smith, K. A. and Uribe, V. (2021). Getting to the Heart of Left-Right Asymmetry: Contributions from 618
the Zebrafish Model. J Cardiovasc Dev Dis 8. 619
Stainier, D. Y. R., Raz, E., Lawson, N. D., Ekker, S. C., Burdine, R. D., Eisen, J. S., Ingham, P. W., 620
Schulte-Merker, S., Yelon, D., Weinstein, B. M., et al. (2017). Guidelines for morpholino use 621
in zebrafish. PLoS Genet 13, e1007000. 622
Thisse, B. and Thisse, C. (2014). In situ hybridization on whole-mount zebrafish embryos and young 623
larvae. Methods Mol Biol 1211, 53-67. 624
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, 625
A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022). Heart Disease 626
and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation 627
145, e153-e639. 628
Veerkamp, J., Rudolph, F., Cseresnyes, Z., Priller, F., Otten, C., Renz, M., Schaefer, L. and 629
Abdelilah-Seyfried, S. (2013). Unilateral dampening of Bmp activity by nodal generates cardiac 630
left-right asymmetry. Dev Cell 24, 660-667. 631
Williams, J. R. (2015). Nodal Directs Asymmetric Cardiac Morphogenesis Through Regulation of Actin 632
Cytoskeleton. In Molecular Biology. Princeton, NJ: Princeton University. 633
Witzel, H. R., Cheedipudi, S., Gao, R., Stainier, D. Y. and Dobreva, G. D. (2017). Isl2b regulates 634
anterior second heart field development in zebrafish. Sci Rep 7, 41043. 635
Woo, S., Housley, M. P., Weiner, O. D. and Stainier, D. Y. (2012). Nodal signaling regulates 636
endodermal cell motility and actin dynamics via Rac1 and Prex1. J Cell Biol 198, 941-952. 637
Yang, S., Weske, A., Du, Y., Valera, J. M., Jones, K. L. and Johnson, A. N. (2020). FGF signaling 638
directs myotube guidance by regulating Rac activity. Development 147. 639
Yelon, D., Horne, S. A. and Stainier, D. Y. (1999). Restricted expression of cardiac myosin genes 640
reveals regulated aspects of heart tube assembly in zebrafish. Dev Biol 214, 23-37. 641
Zeng, X. X. and Yelon, D. (2014). Cadm4 restricts the production of cardiac outflow tract progenitor 642
cells. Cell Rep 7, 951-960. 643
Zhou, Y., Cashman, T. J., Nevis, K. R., Obregon, P., Carney, S. A., Liu, Y., Gu, A., Mosimann, C., 644
Sondalle, S., Peterson, R. E., et al. (2011). Latent TGF-beta binding protein 3 identifies a 645
second heart field in zebrafish. Nature 474, 645-648. 646
647
Figure legends 648
Figure 1. FGF signaling is active in the developing heart and necessary for proper heart 649
development. (A) RNA in situ hybridization (ISH) by hybridization chain reaction (HCR) for fgf8 650
(magenta) and myl7 (green) in the cardiac cone of a 20 hours post fertilization (hpf) wild-type (WT) 651
embryo. Scale = 25 µm. (B) Representative images of 5 days post fertilization (dpf) embryos treated 652
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
with vehicle or FGF inhibitor SU5402 from 24-30 hpf (ventricle in magenta, atrium in cyan). SU5402-653
treated embryos display aberrant cardiac looping, blood pooling at the sinus venosus, and pericardial 654
edema (lateral view) as well as the atrium failing to migrate behind the ventricle (ventral view). (C) ISH 655
for Nodal target gene lefty2 in the cardiac cone of 20 hpf embryos shows correct left-sided lefty2 and 656
incorrect bilateral and absent lefty2 expression. (D) Quantification of lefty2 expression sidedness. n is 657
WT = 74, ntl-/- = 50, spaw-/- = 36, SU5402 = 41, ntl-/- + SU5402 = 177, spaw-/- + SU5402 = 63. Statistical 658
significance was determined by Chi square analysis. (A, C) images are dorsal views, with anterior to 659
the top and left to the reader’s left. ns = not significant, *** = p<0.0001. 660
661
Figure 2. FGF signaling is necessary for proper CPC migration but not cardiac laterality during 662
jogging. (A) Schematization depicting the 18.5-24 hpf SU5402 treatment window during the “Cone 663
Formation and Jogging phase”. (B) RNA ISH for myl7 at 24 hpf displaying the stages from cone 664
through extending to correctly jogged heart tubes we see in our treated embryos. (C) Quantification of 665
cardiac migration phenotypes. Number of embryos (n) is WT = 686, ntl-/- = 152, spaw-/- = 171, SU5402 666
= 531, ntl-/- + SU5402 = 117, spaw-/- + SU5402 = 146. Statistical significance determined by Chi-square 667
analysis. (D) Quantification of heart tube length at 24 hpf. n is WT = 39, ntl-/- = 51, spaw-/- = 32, SU5402 668
= 16. Statistical significance determined by Student’s t-test. (E) RNA ISH for myl7 at 26.5 hpf 669
visualizing correct left-sided positioning and incorrect midline and right-sided positioning of the heart 670
tube. (F) Quantification of cardiac laterality phenotypes. n is WT = 534, ntl-/- = 113, spaw-/- = 138, 671
SU5402 = 112, ntl-/- + SU5402 = 12, spaw-/- + SU5402 = 30. Statistical significance determined by Chi-672
square analysis. (B, E) images are dorsal views, with anterior to the top and left to the reader’s left. ns 673
= not significant, * = p<0.05, *** = p<0.0001. 674
675
Figure 3. FGF signaling promotes CPC migration while Nodal promotes CPC migration and 676
laterality during jogging. (A) Schematization of imaging strategy for time-lapse imaging of the cardiac 677
cone throughout jogging, with outer atrial cells in light green and inner ventricular cells in dark green. 678
Left-sided (blue) and right-sided (orange) cells that underwent tracking for analysis are shown. (B) 679
Representative time-lapse images depicting cardiac progenitor cell (CPC) migration from the formation 680
of the cardiac cone through the next 3 hours of development. WT and ntl-/- embryos typically complete 681
jogging and tube formation in this timeframe. Arrows indicate heart tube direction. Scale = 50 µm. (C) 682
Trajectories of left-sided (blue) and right-sided (orange) CPCs during 3 hours of jogging. Scale = 50 683
µm. (D) Rose plots demonstrating the angle of displacement of each tracked left-sided (blue) and right-684
sided (orange) CPC after 3 hours of jogging. (E) Average velocity of left-sided and right-sided CPCs 685
during 3 hours of jogging. Statistical significance determined by Student's t-test. (C-E) n = 3 embryos (5 686
left-sided and 5 right-sided cells tracked per embryo) per condition. (B-C) images are dorsal views, with 687
anterior to the top and left to the reader’s left. ns = not significant, * = p<0.01. 688
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
689
Figure 4. F-actin dynamics are asymmetric and Nodal-dependent in CPCs during jogging. (A) 690
Tg(myl7:Lifeact-EGFP) embryo at 24 hpf demonstrating the fluorescence of the CPCs composing the 691
heart tube. (B) F-actin protrusive activity in left (blue box) compared to right (orange box) CPCs in the 692
cardiac cone of a Tg(myl7:Lifeact-EGFP) embryo over the course of jogging from 19-23 hpf. (C) F-actin 693
protrusions (pink asterisks) in a singular CPC of a mosaic Tg(myl7:Lifeact-EGFP) embryo at 21 hpf. (D) 694
Cardiac cones of Tg(myl7:Lifeact-EGFP) embryos, with left-sided (blue oval) and right-sided (orange 695
oval) CPCs marked. (E) Schematization of strategy for quantification of fluorescence intensity ratios in 696
the cardiac cone, with the outer atrial cells in light green and the inner ventricular cells in dark green. 697
(F) Fluorescence intensity ratio between left-sided and right-sided CPCs. n is WT = 4, ntl MO = 4, spaw 698
MO = 7, SB-505124 = 5. Statistical significance determined by Student's t-test. (A-D) images are dorsal 699
views, with anterior to the top and left to the reader’s left. ns = not significant, * = p<0.05. 700
701
Figure 5. FGF signaling is necessary for cardiac looping and heart tube extension. (A) 702
Schematization depicting the SU5402 treatment windows during the “Elongation phase” from 24-30 hpf, 703
the “Bending phase” from 30-36 hpf, and the “Continuous treatment” window from 24-48 hpf. (B) 704
Representative images of vehicle and SU5402-treated Tg(myl7:EGFP) embryo hearts at 48 hpf after 705
various SU5402 treatments, depicting how the looping angle is measured (pink lines; AP = 706
anterior/poster axis line and AVC = line through the AVC). (C) Quantification of looping angle in vehicle 707
and SU5402-treated hearts at 48 hpf. n is vehicle = 35, SU5402 elongation phase = 30, SU5402 708
bending phase = 37, spaw-/- = 53, spaw-/- + SU5402 = 22. Student's t-test. (D) Quantification of heart 709
tube length in vehicle and SU5402-treated Tg(nkx2.5:ZsYellow) embryo heart tubes at 26.5 or 28 hpf. n 710
is vehicle 26.5 hpf = 24, SU5402 26.5 hpf = 7, vehicle 28 hpf = 13, SU5402 28 hpf = 19. Student's t-711
test. (B) images are ventral views, with anterior to the top and left to the reader’s right. ns = not 712
significant, * = p<0.05, ** = p<.001, *** = p<0.0001. 713
714
Figure 6. FGF signaling is necessary for proper looping via SHF and necessary for proper AVC 715
development. 716
(A) Representative images of vehicle and ltbp3 morphants at 48 hpf. (B) Quantification of looping 717
angle in vehicle and ltbp3 morphant hearts at 48 hpf. n is vehicle = 29, MO = 50. Student's t-test. (C) 718
RNA ISH for nppa in the heart of 48 hpf embryos. WT vehicle-injected embryos have no nppa 719
expression in the AVC, while SU5402-injected embryos do (black arrows). (D) Quantification of nppa 720
expression pattern of 48 hpf hearts. n is vehicle = 22, SU5402 elongation phase = 7, SU5402 bending 721
phase = 18, spaw-/- = 15, spaw-/- + SU5402 = 13. Chi-square analysis. (A, C) images are ventral views, 722
with anterior to the top and left to the reader’s right. ns = not significant, *** = p<0.0001. 723
724
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
Supplemental Movies 725
Movie S1. Live imaging of CPCs jogging in a WT transgenic Tg(myl7:EGFP) embryo from the onset of 726
cardiac cone formation until three hours after. 727
728
Movie S2. Live imaging of CPCs jogging in a ntl mutant Tg(myl7:EGFP) embryo from the onset of 729
cardiac cone formation until three hours after. 730
731
Movie S3. Live imaging of CPCs jogging in a spaw mutant Tg(myl7:EGFP) embryo from the onset of 732
cardiac cone formation until three hours after. 733
734
Movie S4. Live imaging of CPCs jogging in a SU5402-treated Tg(myl7:EGFP) embryo from the onset 735
of cardiac cone formation until three hours after. 736
737
Movie S5. Live imaging of CPCs jogging in a spaw mutant and SU5402-treated Tg(myl7:EGFP) 738
embryo from the onset of cardiac cone formation until three hours after. 739
740
Movie S6. Live imaging of F-actin in a WT transgenic Tg(myl7:Lifeact-EGFP) embryo from 19-23 hpf, 741
following the cardiac cone as it undergoes jogging. 742
743
Movie S7. Live imaging of F-actin in a singular cardiac precursor cell (CPC) from a WT mosaic 744
Tg(myl7:Lifeact-EGFP) embryo at 21 hours post fertilization (hpf). Movie is a total of 5 minutes. 745
746
Movie S8. Live imaging of F-actin in a spaw morphant Tg(myl7:Lifeact-EGFP) embryo from 19-23 hpf, 747
following the cardiac cone as it undergoes jogging. 748
749
Movie S9. Live imaging of F-actin in a SB-505124-treated Tg(myl7:Lifeact-EGFP) embryo from 19-23 750
hpf, following the cardiac cone as it undergoes jogging. 751
752
Movie S10. Live imaging of F-actin in a ntl morphant Tg(myl7:Lifeact-EGFP) embryo from 19-23 hpf, 753
following the cardiac cone as it undergoes jogging. 754
755
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
756
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
757
758
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
759
760
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
761
762
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
763
764
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
765
766
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint
767
.CC-BY-NC-ND 4.0 International licenseavailable under a
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
The copyright holder for this preprintthis version posted January 6, 2024. ; https://doi.org/10.1101/2024.01.05.574380doi: bioRxiv preprint